Assays to measure estrogen and androgen agonists and antagonists.
暂无分享,去创建一个
C Sonnenschein | F. Olea-Serrano | N. Olea | C. Sonnenschein | A. Soto | A M Soto | N. Prechtl | N Olea | C L Michaelson | N V Prechtl | B C Weill | F Olea-Serrano | C. Michaelson | B. Weill | N. V. Prechtl | B. C. Weill
[1] B. Katzenellenbogen,et al. Estrogenic activity of the insecticide chlordecone (Kepone) and interaction with uterine estrogen receptors. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[2] N. Olea,et al. Development of a marker of estrogenic exposure in human serum. , 1995, Clinical chemistry.
[3] Roger Perkins,et al. QSAR Models for Binding of Estrogenic Compounds to Estrogen Receptor α and β Subtypes. , 1997, Endocrinology.
[4] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] E. A. Doisy,et al. An Ovarian Hormone: Preliminary Report on Its Localization, Extraction and Partial Purification, and Action in Test Animals , 1923 .
[6] J. Nicolas,et al. Stable luciferase transfected cells for studying steroid receptor biological activity. , 1994, Journal of bioluminescence and chemiluminescence.
[7] L. Gray,et al. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. , 1994, Toxicology and applied pharmacology.
[8] G. Murphy,et al. LNCaP model of human prostatic carcinoma. , 1983, Cancer research.
[9] G. Jenster,et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. , 1990, Biochemical and biophysical research communications.
[10] D. Tindall,et al. Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP , 1992, The Prostate.
[11] K. Grandien,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .
[12] C. Sonnenschein,et al. Developing a marker of exposure to xenoestrogen mixtures in human serum. , 1997, Environmental health perspectives.
[13] B. Ozenberger,et al. Selective uptake of estrogenic compounds by Saccharomyces cerevisiae: a mechanism for antiestrogen resistance in yeast expressing the mammalian estrogen receptor. , 1995, Endocrinology.
[14] L. Gray,et al. Persistent DDT metabolite p,p'DDE is a potent androgen receptor antagonist , 1995, Nature.
[15] C. Sonnenschein,et al. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. , 1991, Environmental health perspectives.
[16] D. Tindall,et al. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. , 1991, Cancer research.
[17] C. Sonnenschein,et al. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. , 1997, Endocrinology.
[18] C. Sonnenschein,et al. Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells. , 1984, Biochemical and biophysical research communications.
[19] P. Chambon,et al. Structure of the human oestrogen-responsive gene pS2. , 1987, Nucleic acids research.
[20] C. Portier,et al. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. , 1997, Toxicology and applied pharmacology.
[21] H. A. Padykula,et al. Estrogen action in normal and abnormal cell growth , 1980 .
[22] C Sonnenschein,et al. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. , 1994, Environmental health perspectives.
[23] P. Čepický,et al. [Estrogens in the environment]. , 1986, Ceskoslovenska gynekologie.
[24] I. Schiff,et al. Estrogens in the Environment II: Influences on Development , 1987 .
[25] J. Veldscholte,et al. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids. , 1990, Biochimica et biophysica acta.
[26] N. Olea,et al. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP. , 1990, Endocrinology.
[27] C. Sonnenschein,et al. Cell proliferation of estrogen-sensitive cells: the case for negative control. , 1987, Endocrine reviews.
[28] W S Branham,et al. Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species. , 1997, Environmental health perspectives.
[29] J. Nicolas,et al. Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line. , 1994, Cancer research.
[30] D Gagne,et al. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. , 1990, BioTechniques.
[31] N. Olea,et al. Negative controls of cell proliferation: human prostate cancer cells and androgens. , 1989, Cancer research.
[32] K. Korach,et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Soto,et al. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. , 1993, Environmental health perspectives.
[34] C Sonnenschein,et al. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. , 1995, Environmental health perspectives.
[35] B. Katzenellenbogen,et al. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells. , 1984, Cancer research.
[36] S. Shiau,et al. Activation of the human estrogen receptor by estrogenic and antiestrogenic compounds in Saccharomyces cerevisiae: a positive selection system. , 1995, Gene.